Form SC 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]
SEC Accession No. 0001178913-14-002789
Filing Date
2014-08-28
Accepted
2014-08-28 10:21:00
Documents
1

Document Format Files

Seq Description Document Type Size
1 SC 13D/A zk1415472.htm SC 13D/A 39848
  Complete submission text file 0001178913-14-002789.txt   41544
Mailing Address 2 SNUNIT ST SCIENCE PARK, POB 455 CARMIEL L3 20100
Business Address 2 SNUNIT ST SCIENCE PARK, POB 455 CARMIEL L3 20100 972-4-988-9488
Protalix BioTherapeutics, Inc. (Subject) CIK: 0001006281 (see all company filings)

EIN.: 650643773 | State of Incorp.: FL | Fiscal Year End: 1231
Type: SC 13D/A | Act: 34 | File No.: 005-50118 | Film No.: 141070177
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address MOSHE AVIV TOWER 7 ZABOTINSKY STREET RAMAT GAN L3 52520
Business Address MOSHE AVIV TOWER 7 ZABOTINSKY STREET RAMAT GAN L3 52520 972-3-611-4514
Bio-Cell Ltd (Filed by) CIK: 0001385114 (see all company filings)

EIN.: 000000000
Type: SC 13D/A